Prostaglandin agonists

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Humans1

Associations

1

Osteoporosis

upin humans1

1 study
  1. Prostaglandin agonists are associated with osteoporosis in humans (Osteoporosis incidence: 13.3% with prostaglandin agonists versus 8.9% with muscarinic agonists).

    “Prostaglandin agonist use was associated with an increased risk of osteoporosis compared with muscarinic agonist therapy in POAG patients.”

    HumansPrimary open-angle glaucoma; prostaglandin agonists compared with muscarinic agonists, with 6,743 patients per matched cohortophthalmic medicationsn = 6,743

    Glaucoma eye-drop groups differed in osteoporosis risk

    Journal of orthopaedic surgery (Hong Kong)11 Oct 2026

More on Osteoporosis

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 months
Journal of Orthopaedic Surgery

Glaucoma eye-drop groups differed in osteoporosis risk

Osteoporosis was diagnosed in 13.3% of patients prescribed drops such as latanoprost, compared with 8.9% prescribed drops such as pilocarpine.Osteoporosis was diagnosed in 13.3% of patients prescribed drops such as latanoprost, compared with 8.9% prescribed drops such as pilocarpine.

Cohort study of 6,743 peoplePrimary open-angle glaucoma